Skip to main content
Caplight Logo









Smearcase

Smearcase

Private
New York City, New YorkEnterprise Softwarehttps://smearcase.com/

Last Round

Seed

May 5, 2026

Total Funding Raised

$340,000

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Smearcase is a food products company that produces high-protein, low-fat ice cream made from a cottage cheese base.

Sector

Enterprise Software

Verticals

Content Creation, Creator Economy, User-Generated Content

Business Model

B2C

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

frozen dessertcottage cheese ice creamhigh-protein dessertCPGhealthy ice creamconsumer packaged goodsdirect-to-consumerDTCfunctional foodbetter-for-you snacksfrozen foodretail food

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Smearcase Comparables

Compare Smearcase with similar companies based on industry and business-model similarity.

No public comparables are available for Smearcase. Request access to learn about comparables coverage.

Request access

Smearcase Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 5, 2026
GrantMar 5, 2026
GrantDec 11, 2025
GrantAug 21, 2025
AcceleratorNov 19, 2024

Key People

Founding team and executive leadership

Joseph R. Rotondo

Founder & CEO

Founding Team

Smearcase Investors

Notable investors and investment history

Smearcase investors
InvestorRounds
Listen VenturesSeed
California Milk Advisory BoardGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 15, 2026

    Grew 60% QoQ from 5 to 8 employees.

  • Jun 18, 2026

    Monthly visitors grew 82% MoM.

Smearcase Filings

Explore SEC and related filing metadata, where available.

Smearcase filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Smearcase's valuation, stock price, and market status.

Is Smearcase a public or private company?

Smearcase is a private company.

What is the current stock price of Smearcase?

Smearcase is a private company with no public stock price. No recent secondary market data is available.

How much is Smearcase worth (valuation)?

Valuation information for Smearcase is not publicly available.

Can I buy Smearcase stock?

Smearcase shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Smearcase's last funding round?

Smearcase's most recent funding round was Seed on May 5, 2026.

Who are the main investors in Smearcase?

Key investors in Smearcase include Listen Ventures.

Will Smearcase IPO soon?

No public IPO plans have been announced for Smearcase.

How can I track Smearcase secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Smearcase's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range9
Year Founded2023
Last FundingMay 5, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?